Efficacy and safety of SBR759, a novel calcium‐free, iron(III)‐based phosphate binder, in Asian patients undergoing hemodialysis: A 12‐week, randomized, open‐label, dose‐titration study <i>versus</i> sevelamer hydrochloride - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of SBR759, a novel calcium‐free, iron(III)‐based phosphate binder, in Asian patients undergoing hemodialysis: A 12‐week, randomized, open‐label, dose‐titration study <i>versus</i> sevelamer hydrochloride

26

Citations

16

References

2011

Year

J. F. Chen, Shou-Shan Chiang, HUNG‐CHUN CHEN, Seiichi Obayashi, Masaki Nagasawa, J. Mark Hexham, Alison Balfour, G. Junge, Takashi Akiba, Masafumi Fukagawa

Abstract

SBR759 showed superior phosphate control with a favorable tolerability profile compared to sevelamer-HCl in hemodialysis patients.

References

	Year	Citations

Page 1